Why the confirmed subtype changes the conversation
Lymphoma is an umbrella term. The National Cancer Institute describes it as including Hodgkin lymphoma and non-Hodgkin lymphoma, and the exact diagnosis matters when treatment is discussed. That single sentence carries a lot of practical weight for an overseas patient. If your paperwork says only 'lymphoma', a specialist reading it in China has to work with a much vaguer picture than if it names the specific entity, the tissue or cell type, and how the diagnosis was established.
This is not a bureaucratic detail. Two patients whose files both say 'lymphoma' may be dealing with conditions that behave differently, are staged differently, and are discussed with different treatment goals. A clinician cannot responsibly tell you whether your case fits a particular service, ward or team until the diagnosis is pinned down. So the first useful step is not choosing a hospital. It is confirming what your own records actually say.
You do not need to interpret the pathology yourself. You need to know whether the report you hold is the final diagnostic report, whether it names a subtype, and whether any addendum, molecular study or second opinion has changed it since. If you are unsure, that uncertainty is itself the thing to resolve before you build a travel plan around it.
What 'confirmed subtype' should mean in your file
A confirmed subtype is not the same as a working diagnosis written on a referral note. It usually rests on a pathology report from a tissue sample, and it may include additional studies that refine the classification. The practical question for you is simple: which document is the current, authoritative version, and does it state the subtype clearly?
When you prepare records for any overseas review, it helps to separate what you have from what you are guessing. Ask your treating team or the pathology laboratory which report is final, and whether anything has superseded it. If a report was issued in another language, a certified translation may be needed, but confirm the receiving hospital's own requirement rather than assuming a format.
A useful way to think about it: the subtype is the anchor. Staging information, prior treatment history and current clinical status are all read in relation to that anchor. If the anchor is missing or ambiguous, everything downstream becomes harder to discuss, and a specialist may reasonably ask for clarification rather than offer a view.
- The final pathology report, including any addendum or revised version.
- Any molecular, cytogenetic or immunophenotyping studies that contributed to the classification.
- A clear statement of whether the diagnosis is considered confirmed or still provisional.
- Translations if required, with the source document identifiable.
Planning example: two files, two different next steps
Consider two labelled examples, not real patients. In the first, a file contains a final pathology report naming a specific lymphoma subtype, a staging summary, and a record of treatment to date. The next step is a records-based specialist review focused on whether the current plan is complete, what alternatives exist, and what the treating team would need to see before any in-person visit.
In the second, the file says 'lymphoma, likely' with no final report attached. Here the next step is not booking travel. It is obtaining the definitive report or asking the original pathologist to clarify. A Chinese specialist can still discuss general questions, but any view offered would be conditional, and you should expect the hospital to say so.
The difference matters because it changes what you ask for. In the first case, you are asking for an opinion on a defined problem. In the second, you are asking for help completing a diagnosis, which may be better handled locally first. Neither path is wrong; they simply lead to different actions.
Questions that only make sense once the subtype is clear
Many of the questions overseas patients want answered cannot be answered meaningfully without the subtype. Whether a particular treatment approach is relevant, whether a clinical trial might be worth exploring, whether a transplant assessment is even a topic for discussion, and what monitoring would look like afterwards all depend on the specific diagnosis and the individual clinical picture.
This is also where you should be careful about promises. A records-based review can identify questions, highlight missing information and suggest a direction. It cannot confirm that a hospital will accept you, that a particular therapy is available to you, or that a trial or transplant pathway is open. Those decisions belong to the treating clinicians and the hospital, and they are made case by case.
So when you approach a hospital or a coordination service, phrase your request around the confirmed diagnosis. Ask what they need to see, what they can and cannot assess remotely, and what would remain to be confirmed in person. That framing respects the limits of a paper review and gives you a realistic picture.
- Given this confirmed subtype and stage, what treatment categories are relevant to discuss?
- What records would your team need before offering any view?
- Which parts of my case cannot be assessed without an in-person visit?
- If a trial or transplant pathway is mentioned, what would eligibility review actually involve?
Preparing records without over-sharing or under-sharing
There is a balance between sending everything and sending too little. For an initial enquiry, a brief summary is usually enough: the confirmed subtype if known, the date of diagnosis, the main question you want answered, and a list of the key documents you hold. You do not need to send a complete medical archive at first contact, and you should not send passport numbers or payment details.
Once a review is being arranged, the relevant documents are typically the pathology report, imaging reports and staging information, a summary of treatment received so far, current medications, and any recent clinical notes. Ask the receiving team which of these they want and in what form. Requirements vary, and assuming a format can waste time.
If something is missing, say so rather than leaving a gap that a clinician has to guess at. Missing records should prompt a request for the specific document, not a claim that the case cannot be assessed at all. The goal is a file that lets a specialist understand your situation and tell you what remains uncertain.
What to confirm before you commit to travel
Before arranging travel, you want clarity on several practical points, and these are questions to ask the specific provider rather than assumptions to carry with you. What stage of review are you at: initial enquiry, records-based opinion, or a confirmed appointment? What has the hospital actually agreed to, and what remains provisional? What would happen on arrival, and who would be responsible for each step?
It also helps to ask how the hospital handles the handover back to your home team if you receive care in China. Continuity matters, and the direction of that handover should be planned, not improvised. Ask what documentation you would receive and how your home clinicians would be kept informed.
Finally, keep the clinical decisions where they belong. Suitability, treatment choices and any change to your current care are for the treating clinicians to determine, in consultation with you. A coordination service can help you organise records, understand the process and prepare questions. It does not diagnose, prescribe or decide who is accepted.
If you want to start, a brief initial enquiry is free and does not require buying anything. Share the confirmed subtype if you have it, your main question, and the records you hold. From there, the next step is usually clarifying what is missing and whether a records-based review is worthwhile.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.